Elevated Cell-free DNA After Heart Transplantation - It Ain't Always Rejection: A Case Study Of CMV Infection

Dana Farsakh,Hira Shakoor,Neville Maliakkal,Abbey Hanks,Kayla Funk,Shane Moore,Brenda Astorga,Whitney Whiteley,Shelley Hall,Amit Alam

DOI: https://doi.org/10.1016/j.cardfail.2023.10.409

IF: 6.592

2024-01-01

Journal of Cardiac Failure

Abstract:Introduction Donor-derived cell-free DNA (dd-cfDNA) has been studied as a non-invasive biomarker for post-heart transplant rejection surveillance. However, elevated levels may be seen in patients without evidence of graft dysfunction or rejection. We present a middle-aged heart transplant recipient with CMV Viremia and elevated cfDNA levels. Case report A 43-year-old woman with orthotropic heart transplant nine months prior presented with shortness of breath and was found to have CMV viremia. Her CMV viral load was 113,000 IU/mL and her dd-cfDNA was 0.22%, increased from previous visit of <0.12%. Echo showed no evidence of endocarditis and normal left ventricular systolic function with EF of 65-70%. The patient was negative for any donor specific antibodies. A biopsy was performed and was negative for T-cell mediated rejection and showed no pathologic evidence of antibody-mediated rejection (Grade 0R, pAMR0). A CT scan revealed evidence of CMV pneumonitis. Her symptoms improved with treatment of ganciclovir and cytogam. At two-week follow-up, her CMV viral load dropped to <137 IU/mL and dd-cfDNA returned to <0.12%. (Figure 1) Dd-cfDNA may be elevated in the presence of CMV infection. Further studies are needed to validate these preliminary findings.

cardiac & cardiovascular systems